Cargando…

A scalable, clinically severe pig model for Duchenne muscular dystrophy

Large-animal models for Duchenne muscular dystrophy (DMD) are crucial for the evaluation of diagnostic procedures and treatment strategies. Pigs cloned from male cells lacking DMD exon 52 (DMDΔ52) exhibit molecular, clinical and pathological hallmarks of DMD, but die before sexual maturity and canno...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirm, Michael, Fonteyne, Lina Marie, Shashikadze, Bachuki, Lindner, Magdalena, Chirivi, Maila, Lange, Andreas, Kaufhold, Clara, Mayer, Christian, Medugorac, Ivica, Kessler, Barbara, Kurome, Mayuko, Zakhartchenko, Valeri, Hinrichs, Arne, Kemter, Elisabeth, Krause, Sabine, Wanke, Rüdiger, Arnold, Georg J., Wess, Gerhard, Nagashima, Hiroshi, Hrabĕ de Angelis, Martin, Flenkenthaler, Florian, Kobelke, Levin Arne, Bearzi, Claudia, Rizzi, Roberto, Bähr, Andrea, Reese, Sven, Matiasek, Kaspar, Walter, Maggie C., Kupatt, Christian, Ziegler, Sibylle, Bartenstein, Peter, Fröhlich, Thomas, Klymiuk, Nikolai, Blutke, Andreas, Wolf, Eckhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688409/
https://www.ncbi.nlm.nih.gov/pubmed/34796900
http://dx.doi.org/10.1242/dmm.049285
_version_ 1784618343777435648
author Stirm, Michael
Fonteyne, Lina Marie
Shashikadze, Bachuki
Lindner, Magdalena
Chirivi, Maila
Lange, Andreas
Kaufhold, Clara
Mayer, Christian
Medugorac, Ivica
Kessler, Barbara
Kurome, Mayuko
Zakhartchenko, Valeri
Hinrichs, Arne
Kemter, Elisabeth
Krause, Sabine
Wanke, Rüdiger
Arnold, Georg J.
Wess, Gerhard
Nagashima, Hiroshi
Hrabĕ de Angelis, Martin
Flenkenthaler, Florian
Kobelke, Levin Arne
Bearzi, Claudia
Rizzi, Roberto
Bähr, Andrea
Reese, Sven
Matiasek, Kaspar
Walter, Maggie C.
Kupatt, Christian
Ziegler, Sibylle
Bartenstein, Peter
Fröhlich, Thomas
Klymiuk, Nikolai
Blutke, Andreas
Wolf, Eckhard
author_facet Stirm, Michael
Fonteyne, Lina Marie
Shashikadze, Bachuki
Lindner, Magdalena
Chirivi, Maila
Lange, Andreas
Kaufhold, Clara
Mayer, Christian
Medugorac, Ivica
Kessler, Barbara
Kurome, Mayuko
Zakhartchenko, Valeri
Hinrichs, Arne
Kemter, Elisabeth
Krause, Sabine
Wanke, Rüdiger
Arnold, Georg J.
Wess, Gerhard
Nagashima, Hiroshi
Hrabĕ de Angelis, Martin
Flenkenthaler, Florian
Kobelke, Levin Arne
Bearzi, Claudia
Rizzi, Roberto
Bähr, Andrea
Reese, Sven
Matiasek, Kaspar
Walter, Maggie C.
Kupatt, Christian
Ziegler, Sibylle
Bartenstein, Peter
Fröhlich, Thomas
Klymiuk, Nikolai
Blutke, Andreas
Wolf, Eckhard
author_sort Stirm, Michael
collection PubMed
description Large-animal models for Duchenne muscular dystrophy (DMD) are crucial for the evaluation of diagnostic procedures and treatment strategies. Pigs cloned from male cells lacking DMD exon 52 (DMDΔ52) exhibit molecular, clinical and pathological hallmarks of DMD, but die before sexual maturity and cannot be propagated by breeding. Therefore, we generated female DMD(+/−) carriers. A single founder animal had 11 litters with 29 DMD(Y/−), 34 DMD(+/−) as well as 36 male and 29 female wild-type offspring. Breeding with F1 and F2 DMD(+/−) carriers resulted in an additional 114 DMD(Y/−) piglets. With intensive neonatal management, the majority survived for 3-4 months, providing statistically relevant cohorts for experimental studies. Pathological investigations and proteome studies of skeletal muscles and myocardium confirmed the resemblance to human disease mechanisms. Importantly, DMD(Y/−) pigs displayed progressive myocardial fibrosis and increased expression of connexin-43, associated with significantly reduced left ventricular ejection fraction, at 3 months. Furthermore, behavioral tests provided evidence for impaired cognitive ability. Our breeding cohort of DMDΔ52 pigs and standardized tissue repositories provide important resources for studying DMD disease mechanisms and for testing novel treatment strategies.
format Online
Article
Text
id pubmed-8688409
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-86884092021-12-21 A scalable, clinically severe pig model for Duchenne muscular dystrophy Stirm, Michael Fonteyne, Lina Marie Shashikadze, Bachuki Lindner, Magdalena Chirivi, Maila Lange, Andreas Kaufhold, Clara Mayer, Christian Medugorac, Ivica Kessler, Barbara Kurome, Mayuko Zakhartchenko, Valeri Hinrichs, Arne Kemter, Elisabeth Krause, Sabine Wanke, Rüdiger Arnold, Georg J. Wess, Gerhard Nagashima, Hiroshi Hrabĕ de Angelis, Martin Flenkenthaler, Florian Kobelke, Levin Arne Bearzi, Claudia Rizzi, Roberto Bähr, Andrea Reese, Sven Matiasek, Kaspar Walter, Maggie C. Kupatt, Christian Ziegler, Sibylle Bartenstein, Peter Fröhlich, Thomas Klymiuk, Nikolai Blutke, Andreas Wolf, Eckhard Dis Model Mech Resource Article Large-animal models for Duchenne muscular dystrophy (DMD) are crucial for the evaluation of diagnostic procedures and treatment strategies. Pigs cloned from male cells lacking DMD exon 52 (DMDΔ52) exhibit molecular, clinical and pathological hallmarks of DMD, but die before sexual maturity and cannot be propagated by breeding. Therefore, we generated female DMD(+/−) carriers. A single founder animal had 11 litters with 29 DMD(Y/−), 34 DMD(+/−) as well as 36 male and 29 female wild-type offspring. Breeding with F1 and F2 DMD(+/−) carriers resulted in an additional 114 DMD(Y/−) piglets. With intensive neonatal management, the majority survived for 3-4 months, providing statistically relevant cohorts for experimental studies. Pathological investigations and proteome studies of skeletal muscles and myocardium confirmed the resemblance to human disease mechanisms. Importantly, DMD(Y/−) pigs displayed progressive myocardial fibrosis and increased expression of connexin-43, associated with significantly reduced left ventricular ejection fraction, at 3 months. Furthermore, behavioral tests provided evidence for impaired cognitive ability. Our breeding cohort of DMDΔ52 pigs and standardized tissue repositories provide important resources for studying DMD disease mechanisms and for testing novel treatment strategies. The Company of Biologists Ltd 2021-12-16 /pmc/articles/PMC8688409/ /pubmed/34796900 http://dx.doi.org/10.1242/dmm.049285 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Resource Article
Stirm, Michael
Fonteyne, Lina Marie
Shashikadze, Bachuki
Lindner, Magdalena
Chirivi, Maila
Lange, Andreas
Kaufhold, Clara
Mayer, Christian
Medugorac, Ivica
Kessler, Barbara
Kurome, Mayuko
Zakhartchenko, Valeri
Hinrichs, Arne
Kemter, Elisabeth
Krause, Sabine
Wanke, Rüdiger
Arnold, Georg J.
Wess, Gerhard
Nagashima, Hiroshi
Hrabĕ de Angelis, Martin
Flenkenthaler, Florian
Kobelke, Levin Arne
Bearzi, Claudia
Rizzi, Roberto
Bähr, Andrea
Reese, Sven
Matiasek, Kaspar
Walter, Maggie C.
Kupatt, Christian
Ziegler, Sibylle
Bartenstein, Peter
Fröhlich, Thomas
Klymiuk, Nikolai
Blutke, Andreas
Wolf, Eckhard
A scalable, clinically severe pig model for Duchenne muscular dystrophy
title A scalable, clinically severe pig model for Duchenne muscular dystrophy
title_full A scalable, clinically severe pig model for Duchenne muscular dystrophy
title_fullStr A scalable, clinically severe pig model for Duchenne muscular dystrophy
title_full_unstemmed A scalable, clinically severe pig model for Duchenne muscular dystrophy
title_short A scalable, clinically severe pig model for Duchenne muscular dystrophy
title_sort scalable, clinically severe pig model for duchenne muscular dystrophy
topic Resource Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688409/
https://www.ncbi.nlm.nih.gov/pubmed/34796900
http://dx.doi.org/10.1242/dmm.049285
work_keys_str_mv AT stirmmichael ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT fonteynelinamarie ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT shashikadzebachuki ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT lindnermagdalena ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT chirivimaila ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT langeandreas ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kaufholdclara ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT mayerchristian ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT medugoracivica ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kesslerbarbara ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kuromemayuko ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT zakhartchenkovaleri ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT hinrichsarne ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kemterelisabeth ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT krausesabine ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT wankerudiger ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT arnoldgeorgj ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT wessgerhard ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT nagashimahiroshi ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT hrabedeangelismartin ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT flenkenthalerflorian ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kobelkelevinarne ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT bearziclaudia ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT rizziroberto ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT bahrandrea ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT reesesven ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT matiasekkaspar ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT waltermaggiec ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kupattchristian ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT zieglersibylle ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT bartensteinpeter ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT frohlichthomas ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT klymiuknikolai ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT blutkeandreas ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT wolfeckhard ascalableclinicallyseverepigmodelforduchennemusculardystrophy
AT stirmmichael scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT fonteynelinamarie scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT shashikadzebachuki scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT lindnermagdalena scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT chirivimaila scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT langeandreas scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kaufholdclara scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT mayerchristian scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT medugoracivica scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kesslerbarbara scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kuromemayuko scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT zakhartchenkovaleri scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT hinrichsarne scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kemterelisabeth scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT krausesabine scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT wankerudiger scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT arnoldgeorgj scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT wessgerhard scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT nagashimahiroshi scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT hrabedeangelismartin scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT flenkenthalerflorian scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kobelkelevinarne scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT bearziclaudia scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT rizziroberto scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT bahrandrea scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT reesesven scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT matiasekkaspar scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT waltermaggiec scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT kupattchristian scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT zieglersibylle scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT bartensteinpeter scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT frohlichthomas scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT klymiuknikolai scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT blutkeandreas scalableclinicallyseverepigmodelforduchennemusculardystrophy
AT wolfeckhard scalableclinicallyseverepigmodelforduchennemusculardystrophy